Skip to main content

James Culverwell

Equibles does not estimate personal net worth.

Get an email with a short summary when Quoin Pharmaceuticals Ltd. publishes a filing, an earnings call transcript or a press release.

Get QNRX alerts

About James Culverwell

James Culverwell is recorded as Board Member at Quoin Pharmaceuticals Ltd. (QNRX). The newest filing on record that lists James Culverwell as Board Member at Quoin Pharmaceuticals Ltd. (QNRX) is dated July 16, 2026. Quoin Pharmaceuticals Ltd. reported in an 8-K filed August 20, 2026 that James Culverwell was appointed director, effective August 20, 2026. Quoin Pharmaceuticals Ltd. reported in an 8-K filed December 10, 2024 that James Culverwell was appointed Director, effective December 5, 2024. Quoin Pharmaceuticals Ltd. reported in an 8-K filed November 1, 2023 that James Culverwell was appointed director, effective October 26, 2023. Quoin Pharmaceuticals Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Quoin Pharmaceuticals Ltd. includes Dr. Michael Myers (CEO and Board Member), Sally Lawlor (CFO and Chief Accounting Officer), Denise Carter (COO and Board Member) and 4 others.

“The shareholders elected the following directors to serve as a director of the Company until the Company's next annual general meeting of shareholders and until such director's successor is duly elected and qualified, or until such director's earlier resignation or retirement, based upon the following votes:”
Quoin Pharmaceuticals Ltd. Form 8-K, filed August 20, 2026 · Read the filing
“The shareholders elected the following directors to serve on Quoin's Board of Directors until Quoin's 2025 annual meeting of shareholders and until such director's successor is duly elected and qualified, or until such director's earlier resignation or retirement, based upon the following votes:”
Quoin Pharmaceuticals Ltd. Form 8-K, filed December 10, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Quoin Pharmaceuticals Ltd.

Recent activity